Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Two-Step Haploidentical HSCT for Hematologic Malignancies
NCT01871441Phase 2Terminated
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- May 2013
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in hematologic malignancy, sponsored by Sidney Kimmel Comprehensive Cancer Center. Started May 2013; status: terminated.
02
Drugs
cyclophosphamide
03
Conditions
hematologic malignancy
Beyond the preview
Go deeper on NCT01871441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01871441.